Endothelial cells, fibroblasts and vasculitis

Rheumatology

Volumn 44, Issue 7, 2005, Pages 860-863

  Buckley, Christopher D ^a   Ed Rainger, G ^a   Nash, Gerard B ^a   Raza, Karim ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Vasculitis

Indexed keywords

C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; CELL INTERACTION; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; ISCHEMIC HEART DISEASE; LEUKOCYTE; MICROENVIRONMENT; PATHOLOGY; PERICYTE; PRIORITY JOURNAL; REGULATORY MECHANISM; REMISSION; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SMOOTH MUSCLE FIBER; STROMA CELL; SYSTEMIC VASCULITIS; VASCULAR ENDOTHELIUM; VASCULITIS; CELL COMMUNICATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

CELL COMMUNICATION; ENDOTHELIAL CELLS; FIBROBLASTS; HUMANS; STROMAL CELLS; VASCULITIS;

EID: 22844433793     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keh542     Document Type: Review

References (43)

1. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995;57: 827-72.
2. Hirschi KK, D'Amore PA. Pericytes in the microvasculature. Cardiovasc Res 1996;32:687-98.
3. Ahmad SA, Jung YD, Liu W et al. The role of the microenvironment and intercellular cross-talk in tumor angiogenesis. Semin Cancer Biology 2002;12:105-12.
4. Muller WA. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 2003;24:327-34.
5. Alon R, Feigelson S. From rolling to arrest on blood vessels: Leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts. Semin Immunol 2002;14:93-104.
6. Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002;16:1-4.
7. Yadav R, Larbi KY, Young RE et al. Migration of leukocytes through the vessel wall and beyond. Thromb Haemost 2003;90: 598-606.
8. Chi JT, Chang HY, Haraldsen G et al. Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci USA 2003;100:10623-8.
9. Dai G, Kaazempur-Mofrad MR, Natarajan S et al. Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature. Proc Natl Acad Sci USA 2004;101:14871-6.
10. Choi J, Enis DR, Koh KP et al. T lymphocyte-endothelial cell interactions. Annu Rev Immunol 2004;22:683-709.
11. Nash GB, Buckley CD, Rainger GE. The local physicochemical environment conditions tile proinflammatory response of endothelial cells and thus modulates leukocyte recruitment. FEBS Lett 2004; 569:13-7.
12. Bergers G, Song S, Meyer-Morse N et al. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 2003;111:1287-95.
13. Rainger GE, Nash GB. Cellular pathology of atherosclerosis: Smooth muscle cells prime cocultured endothelial cells for enhanced leukocyte adhesion. Circ Res 2001;88:615-22.
14. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004;432:332-7.
15. Dong J, Grunstein J, Tejada M et al. VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis. EMBO J 2004;23:2800-10.
16. Buckley CD, Pilling D, Lord JM et al. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 2001;22:199-204.
17. Landmesser U, Hornig B, Drexler H. Endothelial function: A critical determinant in atherosclerosis? Circulation 2004;109:II27-33.
18. Hingorani AD, Cross J, Kharbanda RK et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000;102:994-9.
19. Raza K, Thambyrajah J, Townend JN et al. Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation 2000;102:1470-2.
20. Filer AD, Gardner-Medwin JM, Thambyrajah J et al. Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis 2003;62:162-7.
21. Booth AD, Wallace S, McEniery CM et al. Inflammation and arterial stiffness in systemic vasculitis: A model of vascular inflammation. Arthritis Rheum 2004;50:581-8.
22. Booth AD, Jayne DR, Kharbanda RK et al. Infliximab improves endothelial dysfunction in systemic vasculitis: A model of vascular inflammation. Circulation 2004;109:1718-23.
23. Wimalasundera R, Fexby S, Regan L et al. Effect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. Br J Pharmacol 2003;138:1285-94.
24. Chia S, Qadan M, Newton R et al. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler Thromb Vasc Biol 2003;23:695-701.
25. Stevens RJ, Gardner-Medwin JM, Carruthers DM et al. Endothelial dysfunction improves acutely after infliximab. Rheumatology 2002; 41:24.
26. Anderson HD, Rahmutula D, Gardner DG. Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem 2004;279:963-9.
27. Lai PF, Mohamed F, Monge JC et al. Downregulation of eNOS mRNA expression by TNFalpha: Identification and functional characterization of RNA-protein interactions in the 3′UTR. Cardiovasc Res 2003;59:160-8.
28. Corda S, Laplace C, Vicaut E et al. Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide. Am J Respir Cell Mol Biol 2001;24:762-8.
29. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 1997;96: 3042-7.
30. Venugopal SK, Devaraj S, Yuhanna I et al. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002;106:1439-41.
31. Verma S, Wang CH, Li SH et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002;106:913-9.
32. Venugopal SK, Devaraj S, Jialal I. C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation 2003;108:1676-8.
33. Paul A, Ko KW, Li L et al. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004;109:647-55.
34. Hsueh WA, Lyon CJ, Quinones MJ. Insulin resistance and the endothelium. Am J Med 2004;117:109-17.
35. Sattar N, McCarey DW, Capell H et al. Explaining how 'high-grade' systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957-63.
36. Hurlimann D, Forster A, Noll G et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002;106:2184-7.
37. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A et al. HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 2003;114:647-52.
38. El Magadmi M, Bodill H, Ahmad Y et al. Systemic lupus erythematosus: An independent risk factor for endothelial dysfunction in women. Circulation 2004;110:399-404.
39. Banks M, Flint J, Bacon PA, Kitas GD. Rheumatoid arthritis is an independent risk factor for ischaemic heart disease. Arthritis Rheum 2000;43:385.
40. del Rincon ID, Williams K, Stern MP et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44:2737-45.
41. Manzi S, Meilahn EN, Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. Am J Epidemiol 1997;145:408-15.
42. Zaenker M, Aries PM, Herlyn K et al. Accelerated atherosclerosis in Wegener's granulomatosis (WG): A sonographic case-control study on intima media thickness. Arthritis Rheum 2002;46:S185.
43. Salisbury EM, McLaren JS, Jayne DRW et al. Cardiovascular and cerebrovascular disease incidence and risk factors in ANCA-associated primary systemic vasculitis. Rheumatology 2004;43:iI9.